Evidence map›Paper›PMID 39394172›Full record

ArticleParasites & vectors2024

Detection of human strongyloidiasis among patients with a high risk of complications attending selected tertiary care hospitals in Colombo, Sri Lanka using molecular and serological diagnostic tools.

Chamarika Jayanetti Weerasekera, Nayana Gunathilaka, Chandrani Menike, Philip Anpahalan, Nilanka Perera, Nilanthi Renuka de Silva, Renu Wickremasinghe

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Molecular taxonomic study ofFrontiers in parasitology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chamarika Jayanetti WeerasekeraUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka. chamarikajayanetti@sjp.ac.lk.
Nayana GunathilakaUniversity of Kelaniya, Ragama, Sri Lanka.
Chandrani MenikeUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Philip AnpahalanMinistry of Health, Colombo, Sri Lanka.
Nilanka PereraUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Nilanthi Renuka de SilvaUniversity of Kelaniya, Ragama, Sri Lanka.
Renu WickremasingheUniversity of Sri Jayewardenepura, Nugegoda, Sri Lanka.

Funding

University of Sri Jayewardenepura ASP/01/RE/MED/2021/54World Health Organization WHO registration no 2022/1205902-0; Purchase order no - 202805354
6 · The paper itself

Abstract

backgroundStrongyloidiasis a neglected tropical disease is known to cause severe disease among immunosuppressed and has not been studied extensively in Sri Lanka. Parasitological diagnostic approaches based on faecal microscopy and culture often fail to detect low-intensity infections. This study investigates the presence of strongyloidiasis among selected immunocompromised individuals using parasitological, molecular and serological techniques.

methodsAdult patients with immunocompromising conditions admitted to three tertiary care hospitals in Sri Lanka were recruited. A faecal sample and 2 ml of venous blood were collected. The faecal samples were subjected to direct faecal smear and cultures (agar plate, charcoal and Harada-Mori) and polymerase chain reaction (PCR) using species specific primers designed for Strongyloides stercoralis. The presence of Strongyloides IgG antibodies was tested in the collected serum samples using DRG Strongyloides IgG enzyme-linked immunosorbent assay (ELISA) kits. The PCR products of the positive samples were sequenced using Sanger sequencing method.

resultsA total of 260 patients were recruited to this study, out of which 160 provided faecal samples and 122 provided blood samples. Out of the 160 faecal samples, none were positive for strongyloidiasis by direct smear, charcoal and Harada-Mori cultures. Only one sample (0.6%) was positive by agar plate culture. Out of the 123 samples subjected to PCR, 14 (11.4%), including the culture positive patient, were positive for S. stercoralis. Sequencing results of the PCR products indicated 100% similarity to S. stercoralis. Out of the 122 serum samples subjected to ELISA, 20 (16.4%), including the culture positive patient, were positive for Strongyloides IgG antibodies. However, sociodemographic, exposure factors, clinical features were not significantly associated with the presence of strongyloidiasis infection.

conclusionsStrongyloidiasis is present among the immunocompromised population in Sri Lanka, even in the absence of a significant relationship with associated factors. It is advisable to screen such patients with highly sensitive tests such as PCR for early diagnosis and treatment.

Indexed as

Enzyme-Linked Immunosorbent AssayFecesImmunocompromised HostPolymerase Chain ReactionStrongyloides stercoralisStrongyloidiasisTertiary Care CentersAdultAgedAnimalsAntibodies, HelminthFemaleHumansImmunoglobulin GMaleMiddle AgedAntibodies, HelminthImmunoglobulin GImmunocompromisedMolecular diagnosisParasitological diagnosisSerological diagnosisSoil-transmitted helminthStrongyloides stercoralisStrongyloidiasis

Identifiers

PMID39394172
PMCPMC11470637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.